Nicholas Scalzitti, MD
Otolaryngology · Fort Sam Houston, TXNPI 1689965790
Payments from drug & device makers
Across 107 payments — averaging $89.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$7K
- Inspire Medical Systems, Inc.$1K
- Medtronic$340
- Intersect ENT, Inc.$332
- Itamar Medical Inc$249
- Optinose US, Inc.$239
- plus $891 from 12 others
What the payments were for
- Consulting fees$5,30055%
- Travel & lodging$5826%
- Food & beverage$3,74139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 22 | $6,524 |
| Inspire Medical Systems, Inc. | 33 | $1,047 |
| Medtronic | 5 | $340 |
| Intersect ENT, Inc. | 3 | $332 |
| Itamar Medical Inc | 4 | $249 |
| Optinose US, Inc. | 13 | $239 |
| Integra Lifesciences Corporation | 2 | $187 |
| Sanofi | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| Acclarent, Inc | 4 | $87 |
| Stryker | 2 | $86 |
| GSK | 4 | $63 |
| Olympus America Inc. | 1 | $37 |
| ZOLL Respicardia, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Alk-abello, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$6,198
- RHINAER STYLUS$916
- Inspire Upper Airway Stimulation System$441
- PROPEL$339
- Acclarent Aera$156
- Inspira Air$156
- RELIEVA SPINPLUS NAV$156
- TruDi Probe$156
- NUVENT$156
- SINUVA$112
How this compares
$9,623 in reported general payments places this provider in the 85th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 38 | $664 |
| Mupirocin | 49 | $305 |
| Doxycycline Hyclate | 28 | $239 |
| Fluticasone Propionate | 14 | $215 |
| Methylprednisolone | 29 | $173 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $103 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $96 |
| Amoxicillin | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fort Sam Houston
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
- Amber LuongHouston$793K
- Jeffrey RosenbloomSan Antonio$720K
- Masayoshi TakashimaHouston$644K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.